世界の慢性腰痛治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11366)
◆英語タイトル:Global Chronic Low Back Pain Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11366
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥842,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは慢性腰痛治療の世界市場について調査・分析した資料です。種類別(手術、薬品)の市場規模、用途別(病院、クリニック、外来手術センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別慢性腰痛治療の競争状況、市場シェア
・世界の慢性腰痛治療市場:種類別市場規模 2015年-2020年(手術、薬品)
・世界の慢性腰痛治療市場:種類別市場規模予測 2021年-2026年(手術、薬品)
・世界の慢性腰痛治療市場:用途別市場規模 2015年-2020年(病院、クリニック、外来手術センター、その他)
・世界の慢性腰痛治療市場:用途別市場規模予測 2021年-2026年(病院、クリニック、外来手術センター、その他)
・北米の慢性腰痛治療市場分析:米国、カナダ
・ヨーロッパの慢性腰痛治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの慢性腰痛治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の慢性腰痛治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの慢性腰痛治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Johnson & Johnson、Novartis、Takeda Pharmaceutical、Allergan、Teva Pharmaceuticals、Mylan、Stayble Therapeutics、Mesoblast、Axsome Therapeutics
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic.

Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market
The global Chronic Low Back Pain Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chronic Low Back Pain Treatment Scope and Market Size
Chronic Low Back Pain Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Low Back Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Johnson & Johnson
Novartis
Takeda Pharmaceutical
Allergan
Teva Pharmaceuticals
Mylan
Stayble Therapeutics
Mesoblast
Axsome Therapeutics

Market segment by Type, the product can be split into
Surgery
Medication
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Low Back Pain Treatment Revenue
1.4 Market by Type
1.4.1 Global Chronic Low Back Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Medication
1.5 Market by Application
1.5.1 Global Chronic Low Back Pain Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Chronic Low Back Pain Treatment Market Perspective (2015-2026)
2.2 Global Chronic Low Back Pain Treatment Growth Trends by Regions
2.2.1 Chronic Low Back Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Low Back Pain Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Low Back Pain Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Low Back Pain Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Low Back Pain Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Chronic Low Back Pain Treatment Players by Market Size
3.1.1 Global Top Chronic Low Back Pain Treatment Players by Revenue (2015-2020)
3.1.2 Global Chronic Low Back Pain Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Low Back Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Low Back Pain Treatment Market Concentration Ratio
3.2.1 Global Chronic Low Back Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Low Back Pain Treatment Revenue in 2019
3.3 Chronic Low Back Pain Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Low Back Pain Treatment Product Solution and Service
3.5 Date of Enter into Chronic Low Back Pain Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chronic Low Back Pain Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Low Back Pain Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Chronic Low Back Pain Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Low Back Pain Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Chronic Low Back Pain Treatment Market Size (2015-2020)
6.2 Chronic Low Back Pain Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Chronic Low Back Pain Treatment Market Size (2015-2020)
7.2 Chronic Low Back Pain Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

8 China
8.1 China Chronic Low Back Pain Treatment Market Size (2015-2020)
8.2 Chronic Low Back Pain Treatment Key Players in China (2019-2020)
8.3 China Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
8.4 China Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Chronic Low Back Pain Treatment Market Size (2015-2020)
9.2 Chronic Low Back Pain Treatment Key Players in Japan (2019-2020)
9.3 Japan Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
9.4 Japan Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Chronic Low Back Pain Treatment Market Size (2015-2020)
10.2 Chronic Low Back Pain Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

11 India
11.1 India Chronic Low Back Pain Treatment Market Size (2015-2020)
11.2 Chronic Low Back Pain Treatment Key Players in India (2019-2020)
11.3 India Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
11.4 India Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Chronic Low Back Pain Treatment Market Size (2015-2020)
12.2 Chronic Low Back Pain Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Low Back Pain Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chronic Low Back Pain Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Chronic Low Back Pain Treatment Introduction
13.1.4 Pfizer Revenue in Chronic Low Back Pain Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Chronic Low Back Pain Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Chronic Low Back Pain Treatment Introduction
13.3.4 Novartis Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Takeda Pharmaceutical
13.4.1 Takeda Pharmaceutical Company Details
13.4.2 Takeda Pharmaceutical Business Overview
13.4.3 Takeda Pharmaceutical Chronic Low Back Pain Treatment Introduction
13.4.4 Takeda Pharmaceutical Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.4.5 Takeda Pharmaceutical Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Chronic Low Back Pain Treatment Introduction
13.5.4 Allergan Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Details
13.6.2 Teva Pharmaceuticals Business Overview
13.6.3 Teva Pharmaceuticals Chronic Low Back Pain Treatment Introduction
13.6.4 Teva Pharmaceuticals Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.6.5 Teva Pharmaceuticals Recent Development
13.7 Mylan
13.7.1 Mylan Company Details
13.7.2 Mylan Business Overview
13.7.3 Mylan Chronic Low Back Pain Treatment Introduction
13.7.4 Mylan Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.7.5 Mylan Recent Development
13.8 Stayble Therapeutics
13.8.1 Stayble Therapeutics Company Details
13.8.2 Stayble Therapeutics Business Overview
13.8.3 Stayble Therapeutics Chronic Low Back Pain Treatment Introduction
13.8.4 Stayble Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.8.5 Stayble Therapeutics Recent Development
13.9 Mesoblast
13.9.1 Mesoblast Company Details
13.9.2 Mesoblast Business Overview
13.9.3 Mesoblast Chronic Low Back Pain Treatment Introduction
13.9.4 Mesoblast Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.9.5 Mesoblast Recent Development
13.10 Axsome Therapeutics
13.10.1 Axsome Therapeutics Company Details
13.10.2 Axsome Therapeutics Business Overview
13.10.3 Axsome Therapeutics Chronic Low Back Pain Treatment Introduction
13.10.4 Axsome Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2015-2020)
13.10.5 Axsome Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Chronic Low Back Pain Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Low Back Pain Treatment Revenue
Table 3. Ranking of Global Top Chronic Low Back Pain Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Low Back Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Medication
Table 7. Global Chronic Low Back Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Chronic Low Back Pain Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Chronic Low Back Pain Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Chronic Low Back Pain Treatment Market Share by Regions (2015-2020)
Table 11. Global Chronic Low Back Pain Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Chronic Low Back Pain Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Chronic Low Back Pain Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Chronic Low Back Pain Treatment Players
Table 18. Global Chronic Low Back Pain Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Chronic Low Back Pain Treatment Market Share by Players (2015-2020)
Table 20. Global Top Chronic Low Back Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Low Back Pain Treatment as of 2019)
Table 21. Global Chronic Low Back Pain Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chronic Low Back Pain Treatment Product Solution and Service
Table 24. Date of Enter into Chronic Low Back Pain Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Chronic Low Back Pain Treatment Market Size Share by Type (2015-2020)
Table 28. Global Chronic Low Back Pain Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Chronic Low Back Pain Treatment Market Size Share by Application (2015-2020)
Table 30. Global Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Chronic Low Back Pain Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 34. North America Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 36. North America Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 40. Europe Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 42. Europe Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 46. China Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 48. China Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 52. Japan Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 54. Japan Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 58. Southeast Asia Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 64. India Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 66. India Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Chronic Low Back Pain Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Chronic Low Back Pain Treatment Market Share (2019-2020)
Table 70. Central & South America Chronic Low Back Pain Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Chronic Low Back Pain Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Chronic Low Back Pain Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Chronic Low Back Pain Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Takeda Pharmaceutical Company Details
Table 90. Takeda Pharmaceutical Business Overview
Table 91. Takeda Pharmaceutical Product
Table 92. Takeda Pharmaceutical Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 93. Takeda Pharmaceutical Recent Development
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Product
Table 97. Allergan Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 98. Allergan Recent Development
Table 99. Teva Pharmaceuticals Company Details
Table 100. Teva Pharmaceuticals Business Overview
Table 101. Teva Pharmaceuticals Product
Table 102. Teva Pharmaceuticals Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 103. Teva Pharmaceuticals Recent Development
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Product
Table 107. Mylan Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 108. Mylan Recent Development
Table 109. Stayble Therapeutics Business Overview
Table 110. Stayble Therapeutics Product
Table 111. Stayble Therapeutics Company Details
Table 112. Stayble Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 113. Stayble Therapeutics Recent Development
Table 114. Mesoblast Company Details
Table 115. Mesoblast Business Overview
Table 116. Mesoblast Product
Table 117. Mesoblast Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 118. Mesoblast Recent Development
Table 119. Axsome Therapeutics Company Details
Table 120. Axsome Therapeutics Business Overview
Table 121. Axsome Therapeutics Product
Table 122. Axsome Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2015-2020) (Million US$)
Table 123. Axsome Therapeutics Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Low Back Pain Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Medication Features
Figure 4. Global Chronic Low Back Pain Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Chronic Low Back Pain Treatment Report Years Considered
Figure 10. Global Chronic Low Back Pain Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Chronic Low Back Pain Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Chronic Low Back Pain Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Chronic Low Back Pain Treatment Market Share by Players in 2019
Figure 15. Global Top Chronic Low Back Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Low Back Pain Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Chronic Low Back Pain Treatment Revenue in 2019
Figure 17. North America Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Chronic Low Back Pain Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed


【掲載企業】

Pfizer、Johnson & Johnson、Novartis、Takeda Pharmaceutical、Allergan、Teva Pharmaceuticals、Mylan、Stayble Therapeutics、Mesoblast、Axsome Therapeutics

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の慢性腰痛治療市場2026:インサイト・予測(Global Chronic Low Back Pain Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。